Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged more than 18 years 2. Patients who have successfully completed the informed consent process prior to their participation. 3. Patients who are willing to provide the clinical pictures (Pre -operative and postoperative) 4. Patients who are willing to use the Cicaderm spray for 7-14 days as per the physician’s prescription.
Exclusion criteria
Exclusion criteria: Patients who are unwilling to provide the consent Patients who are undergoing any cancer treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the efficacy of Cicaderm extract spray after dermatological procedures as post procedure skin care. Timepoint: Baseline visit 0-7 days : Data Collection Efficacy and safety will be analysed in Follow up visits time line :7-14 days | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the safety of Cicaderm spray Evaluate the cosmetic qualities and the perception of effectivenessTimepoint: Day 1 to 14 days | — |
Countries
India
Contacts
Docmode Health